NovaXS Biotech

Early Stage

Needle-free self-injection technology | Ease of use, painless, better care

Overview

Raised to Date: Raised: $109,198

Total Commitments ($USD)

Platform

Republic

Start Date

12/06/2022

Close Date

02/03/2023

Min. Goal

$25,000

Max. Goal

$1,235,000

Min. Investment

$100

Security Type

SAFE

Series

Seed

Funding Type

RegCF

Valuation Cap

$14,000,000

Discount Rate

20%

Rolling Commitments ($USD)

Status

Active

Reporting Date

02/03/2023

Days Remaining

0

% of Min. Goal

437%

% of Max. Goal

9%

Likelihood of Max
unlikely
Avg. Daily Raise

$1,851

# of Investors

212

Momentum
cold.svg
Create a free account today to gain access to KingsCrowd analytics.
Location

Trabuco Canyon, California

Industry

Healthcare & Pharmaceuticals

Tech Sector

Biotech

Distribution Model

B2B

Margin

Medium

Capital Intensity

Low

Business Type

Growth

NovaXS Biotech, with a valuation of $14 million, is raising funds on Republic. The company is developing needle-free self-injection technology for ease of use, painless drug delivery, and better care. NovaXS Biotech smart system aims to simplify the medication self-administration process and improve remote treatment outcomes with one simple click on the device. NovaXS Biotech has filed four patents to protect its technology, is finalizing prototypes, and targeting commercial launch in the second quarter of 2024. Alina Su, Jonathan Xing, and Alex You founded NovaXS Biotech in January 2021. The current crowdfunding campaign has a minimum target of $25,000 and a maximum target of $1.24 million. The campaign proceeds will be used to initiate licensing, launch the product, and promote sales.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-62,494

$0

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$297,216

$0

Accounts Receivable

$0

$0

Total Assets

$297,216

$0

Short-Term Debt

$7,872

$0

Long-Term Debt

$290,000

$0

Total Liabilities

$297,872

$0

Financials as of: 12/06/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$12.42 /month
billed annually
Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings (excluding risk)
Advanced company search ( with ratings)
Markets page filters and historical industry data
Get Edge Annual

Edge Pro

$41.58 /month
billed annually
Full site access including KingsCrowd's qualitative analyst reports.
Plan Includes:
Everything in Edge, plus
Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
Search and filter based on Analyst Reports
In-depth risk ratings for every raise
Get Edge Pro Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
NovaXS Biotech on Republic 2022
$
Platform: Republic
Security Type: SAFE
Valuation: $14,000,000

Follow company

Follow NovaXS Biotech on Republic 2022
View on Republic